14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ATON vs MREO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Mereo BioPharma Group plc (MREO) is the stronger overall head-to-head candidate over AlphaTON Capital Corp. (ATON) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ATON carries a Unified Composite Score of 45.1/100 (HOLD) at $0.32 (N/M Forward P/E, 0.0% operating margin), whereas MREO carries 46.9/100 (HOLD) at $0.30 (113.9x Forward P/E, -3702.5% operating margin).
Technical & Structure Timing Caution: ATON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile MREO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ATON vs MREO. Trailing 12-month operating profitability (ATON 0.0% vs MREO -3702.5%) and valuation multiples (ATON N/M vs MREO 113.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $48.7M market capitalization and -3702.5% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ATON vs MREO Key Questions & Quantitative Answers
As of Nov 16, 2026, Mereo BioPharma Group plc (MREO) is the stronger overall head-to-head candidate over AlphaTON Capital Corp. (ATON) in the Tradestie Institutional Equity Comparison Engine, winning 6–1 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ATON carries a Unified Composite Score of 45.1/100 (HOLD) at $0.32 (N/M Forward P/E, 0.0% operating margin), whereas MREO carries 46.9/100 (HOLD) at $0.30 (113.9x Forward P/E, -3702.5% operating margin). Technical & Structure Timing Caution: ATON is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.3); meanwhile MREO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 50.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MREO leads the Growth & Scale pillar: ATON posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with MREO at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $800,000 TTM revenue (100.0% gross margin, -3702.5% operating margin). On trailing 12-month operating scale, ATON generates N/A in USD-normalized revenue versus $800,000 for MREO. In operating R&D and SG&A reinvestment, ATON deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MREO.
MREO screens cheaper on headline valuation multiples. ATON trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MREO trades at 113.9x Forward P/E, N/M Trailing P/E, N/M PEG, and 60.9x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ATON (-311.0% ROE) versus MREO (-76.6% ROE) capital efficiency.
In options market volatility and institutional positioning, ATON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.90β · 65% Vol realized risk). By comparison, MREO carries 0.5% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.09β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.